Income Statement Toyota Industries Corporation

Equities

6201

JP3634600005

Heavy Machinery & Vehicles

Delayed Japan Exchange Other stock markets 06:46:09 11/05/2026 BST			5-day change	1st Jan Change
20,425.00 ^JPY	-0.02%		-0.02%	+14.75%

06:46am	Toyota to build new 100,000-units-a-year car factory in India	RE
06:01am	US industry, lawmakers plead with Trump: Don't open door to Chinese cars at Xi summit	RE

3478a5123517bc5b87252db9.98Pdn98XLBxBHdDJZlkApJaMAn-scEkwCVgIxCfxDGk.qIKo9KxOYUx0f5OHMx445sDLVBfeRR4FeTAw_UqoaFuohLHbvG1ESg4o5A

Published financial data: TOYOTA INDUSTRIES CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,118B	2,705B	3,380B	3,833B	4,085B
Total Revenues	2,118B	2,705B	3,380B	3,833B	4,085B
Cost of Goods Sold, Total	1,628B	2,098B	2,624B	2,932B	3,133B
Gross Profit	490B	608B	756B	901B	952B
Selling General & Admin Expenses, Total	375B	455B	577B	657B	724B
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-3.88B	-7.15B	9.78B	43.76B	6.64B
Other Operating Expenses, Total	371B	448B	587B	701B	730B
Operating Income	120B	160B	170B	201B	221B
Interest Expense, Total	-5.43B	-4.87B	-10.11B	-16.99B	-11.17B
Interest And Investment Income	72.43B	84.2B	95.42B	122B	142B
Net Interest Expenses	67B	79.33B	85.31B	105B	130B
Income (Loss) On Equity Invest.	1.68B	4.4B	3.31B	3.28B	2.62B
Currency Exchange Gains (Loss)	-2.55B	3.48B	4.87B	1.84B	-2.01B
Other Non Operating Income (Expenses)	624M	747M	457M	-211M	-328M
EBT, Excl. Unusual Items	186B	248B	264B	310B	352B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-2.39B	-1.5B	-627M	-1.12B	-359M
EBT, Incl. Unusual Items	184B	246B	263B	309B	351B
Income Tax Expense	42.58B	60.77B	64.25B	72.34B	80.22B
Earnings From Continuing Operations	141B	185B	199B	237B	271B
Net Income to Company	141B	185B	199B	237B	271B
Minority Interest	-4.74B	-5.04B	-5.86B	-8.08B	-8.93B
Net Income - (IS)	137B	180B	193B	229B	262B
Net Income to Common Incl Extra Items	137B	180B	193B	229B	262B
Net Income to Common Excl. Extra Items	137B	180B	193B	229B	262B
Per Share Items
Net EPS - Basic	440.28	580.73	621.17	736.86	856.96
Basic EPS - Continuing Operations	440.28	580.73	621.17	736.86	856.96
Basic Weighted Average Shares Outstanding	310M	310M	310M	310M	306M
Net EPS - Diluted	440.28	580.73	621.17	736.86	856.96
Diluted EPS - Continuing Operations	440.28	580.73	621.17	736.86	856.96
Diluted Weighted Average Shares Outstanding	310M	310M	310M	310M	306M
Normalized Basic EPS	359.97	482.22	511.76	598.65	689.17
Normalized Diluted EPS	359.97	482.22	511.76	598.65	689.17
Dividend Per Share	150	170	190	240	280
Payout Ratio	34.07	27.55	28.98	27.14	32.91
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	329B	383B	427B	486B	545B
EBITA	120B	160B	170B	201B	221B
EBIT	120B	160B	170B	201B	221B
Effective Tax Rate - (Ratio)	23.14	24.69	24.43	23.4	22.82
Normalized Net Income	112B	150B	159B	186B	211B
Non-Cash Pension Expense	13.95B	13.7B	16.86B	20.24B	24.48B
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	76.78B	87.77B	105B	122B	127B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	592B	576B	623B	740B	468B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	592B	576B	623B	740B	468B
Accounts Receivable, Total	962B	1,121B	1,399B	1,639B	1,721B
Other Receivables	22.63B	28.91B	26.26B	14.49B	63.84B
Total Receivables	985B	1,150B	1,425B	1,653B	1,784B
Inventory	292B	434B	524B	619B	620B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	78.61B	95.71B	105B	117B	237B
Total Current Assets	1,948B	2,256B	2,677B	3,130B	3,109B
Net Property Plant And Equipment	1,043B	1,134B	1,238B	1,448B	1,537B
Long-term Investments	3,111B	3,801B	3,400B	5,911B	4,148B
Goodwill	171B	192B	232B	268B	273B
Other Intangibles, Total	193B	204B	237B	270B	279B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	37.62B	39.91B	37.99B	51.6B	57.32B
Other Long-Term Assets, Total	5M	4M	2M	4M	4M
Total Assets	6,504B	7,627B	7,821B	11,078B	9,403B
Liabilities
Accounts Payable, Total	614B	746B	807B	877B	879B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	75.64B	182B	291B	221B	234B
Current Portion of Long-Term Debt	360B	286B	229B	204B	263B
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	22.79B	27.28B	29.7B	110B	32.2B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	117B	131B	160B	228B	196B
Total Current Liabilities	1,188B	1,373B	1,517B	1,639B	1,604B
Long-Term Debt	910B	922B	1,179B	1,282B	1,233B
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	105B	91.68B	81.42B	68.77B	74.08B
Deferred Tax Liability Non Current	855B	1,079B	953B	1,730B	1,235B
Other Non Current Liabilities	124B	140B	155B	205B	242B
Total Liabilities	3,181B	3,605B	3,886B	4,925B	4,388B
Common Stock, Total	80.46B	80.46B	80.46B	80.46B	80.46B
Additional Paid In Capital	102B	102B	101B	99.58B	99.46B
Retained Earnings	1,370B	1,515B	1,653B	1,990B	2,194B
Treasury Stock	-59.32B	-59.34B	-59.34B	-59.37B	-168B
Comprehensive Income and Other	1,743B	2,290B	2,062B	3,935B	2,699B
Total Common Equity	3,236B	3,929B	3,837B	6,046B	4,905B
Minority Interest	86.51B	93.45B	97.98B	108B	111B
Total Equity	3,323B	4,022B	3,935B	6,153B	5,015B
Total Liabilities And Equity	6,504B	7,627B	7,821B	11,078B	9,403B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	310M	310M	310M	310M	300M
ECS Total Common Shares Outstanding	310M	310M	310M	310M	301M
Book Value / Share	10.42K	12.65K	12.36K	19.47K	16.27K
Tangible Book Value	2,873B	3,533B	3,369B	5,508B	4,353B
Tangible Book Value Per Share	9.25K	11.38K	10.85K	17.74K	14.44K
Total Debt	1,345B	1,391B	1,699B	1,706B	1,730B
Net Debt	753B	815B	1,076B	966B	1,262B
Debt Equivalent of Unfunded Proj. Benefit Obligation	53.48B	32.45B	23.22B	-17.68B	-7.42B
Minority Interest, Total (Incl. Fin. Div)	86.51B	93.45B	97.98B	108B	111B
Equity Method Investments, Total	16.81B	21.34B	23.99B	30.02B	23.8B
Inventories - Raw Materials, Total	80.61B	122B	132B	149B	141B
Inventories - Work In Process, Total	72.37B	109B	136B	143B	123B
Inventories - Finished Goods, Total	139B	203B	256B	328B	355B
Inventories - Others	1M	-	1M	2M	1M
Full Time Employees	66.95K	71.78K	74.89K	77.82K	79.45K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-
Order Backlog	1,042B	1,309B	1,414B	1,615B	1,536B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	184B	246B	263B	309B	351B
Depreciation & Amortization - CF	210B	224B	258B	285B	324B
Depreciation & Amortization, Total	210B	224B	258B	285B	324B
(Gain) Loss From Sale Of Asset	3.01B	2.37B	2.63B	5.98B	1.15B
(Income) Loss On Equity Investments - (CF)	-1.68B	-4.4B	-3.31B	-3.28B	-2.62B
Other Operating Activities, Total	-52.16B	-60.92B	-66.25B	-79.64B	-213B
Change In Accounts Receivable	-40.04B	-81.25B	-225B	-82.98B	-91.21B
Change In Inventories	-20.67B	-111B	-70.21B	-28.39B	-4.84B
Change In Accounts Payable	73.87B	93.54B	29.62B	7.69B	13.07B
Change in Other Net Operating Assets	26.2B	12.5B	7.24B	30.08B	-207B
Cash from Operations	382B	321B	195B	444B	172B
Capital Expenditure	-222B	-237B	-290B	-349B	-211B
Sale of Property, Plant, and Equipment	16.2B	16.42B	19.66B	28.02B	5.42B
Cash Acquisitions	-714M	-14.9B	-36.49B	-7.92B	-7.76B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-182B	25.02B	-88.74B	420B	232B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-74M	-	-	-	-
Other Investing Activities, Total	-15.17B	-18.97B	-32.1B	-43.4B	-62.23B
Cash from Investing	-404B	-230B	-428B	47.9B	-43.4B
Short Term Debt Issued, Total	64.35B	177B	254B	64.48B	102B
Long-Term Debt Issued, Total	229B	247B	458B	308B	231B
Total Debt Issued	294B	423B	712B	372B	333B
Short Term Debt Repaid, Total	-79.5B	-85.74B	-158B	-174B	-84.22B
Long-Term Debt Repaid, Total	-184B	-365B	-296B	-316B	-210B
Total Debt Repaid	-263B	-450B	-454B	-490B	-294B
Repurchase of Common Stock	-14M	-18M	-5M	-24M	-109B
Common Dividends Paid	-46.57B	-49.68B	-55.89B	-62.1B	-86.34B
Common & Preferred Stock Dividends Paid	-46.57B	-49.68B	-55.89B	-62.1B	-86.34B
Other Financing Activities, Total	-89.3B	-15.56B	-18.06B	-29.86B	-41.86B
Cash from Financing	-105B	-92.11B	184B	-209B	-199B
Foreign Exchange Rate Adjustments	7.36B	9.67B	4.63B	12.11B	-1.04B
Miscellaneous Cash Flow Adjustments	-	-	3M	2M	-46.87B
Net Change in Cash	-120B	8.84B	-44.35B	294B	-118B
Supplemental Items
Cash Interest Paid	5.43B	5B	9.92B	18.11B	11.11B
Cash Income Tax Paid (Refund)	52.6B	61.51B	66.94B	78.97B	214B
Levered Free Cash Flow	17.24B	-89.77B	-213B	-67.06B	-115B
Unlevered Free Cash Flow	20.64B	-86.73B	-207B	-56.45B	-108B
Change In Net Working Capital	41.62B	173B	281B	118B	360B
Net Debt Issued / Repaid	30.41B	-26.86B	258B	-118B	38.73B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.27	1.41	1.37	1.33	1.35
Return on Total Capital	1.75	1.98	1.92	1.86	1.89
Return On Equity %	4.84	5.05	4.99	4.7	4.86
Return on Common Equity	4.82	5.03	4.97	4.63	4.79
Margin Analysis
Gross Profit Margin %	23.15	22.46	22.37	23.51	23.29
SG&A Margin	17.69	16.83	17.06	17.13	17.72
EBITDA Margin %	15.55	14.17	12.65	12.67	13.34
EBITA Margin %	5.65	5.9	5.02	5.23	5.41
EBIT Margin %	5.65	5.9	5.02	5.23	5.41
Income From Continuing Operations Margin %	6.68	6.85	5.88	6.18	6.64
Net Income Margin %	6.45	6.67	5.71	5.97	6.42
Net Avail. For Common Margin %	6.45	6.67	5.71	5.97	6.42
Normalized Net Income Margin	5.28	5.53	4.7	4.85	5.16
Levered Free Cash Flow Margin	0.81	-3.32	-6.31	-1.75	-2.83
Unlevered Free Cash Flow Margin	0.97	-3.21	-6.13	-1.47	-2.65
Asset Turnover
Asset Turnover	0.36	0.38	0.44	0.41	0.4
Fixed Assets Turnover	2.08	2.48	2.85	2.85	2.74
Receivables Turnover (Average Receivables)	2.32	2.6	2.68	2.52	2.43
Inventory Turnover (Average Inventory)	5.94	5.77	5.48	5.13	5.06
Short Term Liquidity
Current Ratio	1.64	1.64	1.76	1.91	1.94
Quick Ratio	1.33	1.26	1.35	1.46	1.4
Operating Cash Flow to Current Liabilities	0.32	0.23	0.13	0.27	0.11
Days Sales Outstanding (Average Receivables)	157.61	140.58	136.08	145.02	150.09
Days Outstanding Inventory (Average Inventory)	61.46	63.2	66.66	71.37	72.16
Average Days Payable Outstanding	124.21	110.78	104.43	101.84	102.24
Cash Conversion Cycle (Average Days)	94.86	93	98.32	114.55	120.01
Long Term Solvency
Total Debt/Equity	40.49	34.57	43.18	27.73	34.5
Total Debt / Total Capital	28.82	25.69	30.16	21.71	25.65
LT Debt/Equity	27.39	22.92	29.97	20.83	24.58
Long-Term Debt / Total Capital	19.5	17.03	20.93	16.31	18.28
Total Liabilities / Total Assets	48.92	47.27	49.68	44.46	46.67
EBIT / Interest Expense	22.04	32.8	16.78	11.81	19.79
EBITDA / Interest Expense	60.7	78.76	42.28	28.58	48.79
(EBITDA - Capex) / Interest Expense	19.73	30	13.59	8.04	29.91
Total Debt / EBITDA	4.08	3.63	3.98	3.51	3.17
Net Debt / EBITDA	2.29	2.13	2.52	1.99	2.31
Total Debt / (EBITDA - Capex)	12.56	9.52	12.36	12.49	5.18
Net Debt / (EBITDA - Capex)	7.03	5.58	7.83	7.07	3.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.44	27.71	24.94	13.41	6.57
Gross Profit, 1 Yr. Growth %	-3.16	23.91	24.44	19.17	5.6
EBITDA, 1 Yr. Growth %	-2.53	16.37	11.48	13.61	12.27
EBITA, 1 Yr. Growth %	-7.77	33.45	6.25	18.27	10.19
EBIT, 1 Yr. Growth %	-7.77	33.45	6.25	18.27	10.19
Earnings From Cont. Operations, 1 Yr. Growth %	-5.83	31.05	7.21	19.19	14.52
Net Income, 1 Yr. Growth %	-6.29	31.9	6.96	18.62	14.66
Normalized Net Income, 1 Yr. Growth %	-6.75	33.96	6.13	16.98	13.5
Diluted EPS Before Extra, 1 Yr. Growth %	-6.29	31.9	6.96	18.62	16.3
Accounts Receivable, 1 Yr. Growth %	10.98	16.55	24.72	17.18	4.98
Inventory, 1 Yr. Growth %	14.36	48.38	20.84	18.06	0.12
Net Property, Plant and Equip., 1 Yr. Growth %	5.27	8.69	9.12	17.03	6.14
Total Assets, 1 Yr. Growth %	23.19	17.27	2.54	41.65	-15.12
Tangible Book Value, 1 Yr. Growth %	37.83	22.98	-4.63	63.48	-20.97
Common Equity, 1 Yr. Growth %	32.69	21.4	-2.32	57.55	-18.87
Cash From Operations, 1 Yr. Growth %	22.09	-16.03	-39.28	127.52	-61.32
Capital Expenditures, 1 Yr. Growth %	2.94	6.75	22.16	20.33	-39.52
Levered Free Cash Flow, 1 Yr. Growth %	-79.63	-620.56	137.73	-68.58	72.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-76.65	-520.24	138.79	-72.74	92.09
Dividend Per Share, 1 Yr. Growth %	-6.25	13.33	11.76	26.32	16.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.21	11.62	26.32	19.04	9.94
Gross Profit, 2 Yr. CAGR %	-2.16	9.54	24.18	21.78	12.18
EBITDA, 2 Yr. CAGR %	1.32	6.5	13.9	12.54	12.94
EBITA, 2 Yr. CAGR %	-5.85	10.94	19.08	12.1	14.16
EBIT, 2 Yr. CAGR %	-5.85	10.94	19.08	12.1	14.16
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.91	11.09	18.53	13.04	16.83
Net Income, 2 Yr. CAGR %	-5.4	11.17	18.78	12.64	16.62
Normalized Net Income, 2 Yr. CAGR %	-3.52	11.77	19.23	11.42	15.22
Diluted EPS Before Extra, 2 Yr. CAGR %	-5.4	11.18	18.78	12.64	17.46
Accounts Receivable, 2 Yr. CAGR %	6.7	13.73	20.57	20.89	10.91
Inventory, 2 Yr. CAGR %	9.22	30.26	33.9	19.44	8.72
Net Property, Plant and Equip., 2 Yr. CAGR %	5.47	6.96	8.91	13.01	11.46
Total Assets, 2 Yr. CAGR %	11.19	20.19	9.66	20.52	9.65
Tangible Book Value, 2 Yr. CAGR %	16.44	30.19	8.3	24.86	13.67
Common Equity, 2 Yr. CAGR %	14.24	26.92	8.9	24.05	13.05
Cash From Operations, 2 Yr. CAGR %	18.94	1.25	-28.6	17.54	-6.19
Capital Expenditures, 2 Yr. CAGR %	-0.73	4.83	14.2	21.24	-14.69
Levered Free Cash Flow, 2 Yr. CAGR %	-39.31	2.97	251.79	-13.57	-26.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.69	-0.95	216.78	-19.32	-27.64
Dividend Per Share, 2 Yr. CAGR %	-1.63	3.08	12.55	18.82	21.4
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.87	6.89	15.89	21.86	14.73
Gross Profit, 3 Yr. CAGR %	1.44	5.85	14.3	22.48	16.12
EBITDA, 3 Yr. CAGR %	2.02	6.11	8.13	13.8	12.45
EBITA, 3 Yr. CAGR %	-6.8	5.76	9.36	18.81	11.46
EBIT, 3 Yr. CAGR %	-6.8	5.76	9.36	18.81	11.46
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.64	5.07	9.78	18.75	13.53
Net Income, 3 Yr. CAGR %	-6.68	5.68	9.75	18.73	13.31
Normalized Net Income, 3 Yr. CAGR %	-3.98	7.63	9.86	18.48	12.11
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.67	5.68	9.75	18.73	13.85
Accounts Receivable, 3 Yr. CAGR %	7.97	9.88	17.28	19.42	15.34
Inventory, 3 Yr. CAGR %	9.34	20.96	27.04	28.4	12.62
Net Property, Plant and Equip., 3 Yr. CAGR %	5.47	6.53	7.68	11.55	10.67
Total Assets, 3 Yr. CAGR %	7.34	13.18	14	19.43	7.23
Tangible Book Value, 3 Yr. CAGR %	9.44	18.58	17.36	24.23	7.21
Common Equity, 3 Yr. CAGR %	8.22	16.58	16.31	23.16	7.68
Cash From Operations, 3 Yr. CAGR %	12.5	5.91	-14.62	5.07	-18.85
Capital Expenditures, 3 Yr. CAGR %	3.58	1.71	10.31	16.21	-3.84
Levered Free Cash Flow, 3 Yr. CAGR %	-54.24	24.23	36.09	57.26	8.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	-51.85	27.6	32.81	39.85	7.73
Dividend Per Share, 3 Yr. CAGR %	0	3.13	5.9	16.96	18.1
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.01	10.06	11.02	11.59	13.47
Gross Profit, 5 Yr. CAGR %	2.94	8.9	9.99	11.96	13.44
EBITDA, 5 Yr. CAGR %	3.46	6.71	6.61	8.64	10.03
EBITA, 5 Yr. CAGR %	-1.34	4.5	2.79	8.25	11.25
EBIT, 5 Yr. CAGR %	-1.34	4.5	2.79	8.25	11.25
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.91	6.14	2.71	8.19	12.55
Net Income, 5 Yr. CAGR %	-5.67	6.53	2.78	8.41	12.45
Normalized Net Income, 5 Yr. CAGR %	0.68	6.63	4.71	9.13	11.97
Diluted EPS Before Extra, 5 Yr. CAGR %	-5.45	6.66	2.78	8.42	12.77
Accounts Receivable, 5 Yr. CAGR %	22.56	11.65	12.84	14.16	14.69
Inventory, 5 Yr. CAGR %	8.2	17.42	18.57	20.35	19.37
Net Property, Plant and Equip., 5 Yr. CAGR %	5.96	6.36	6.83	9.08	9.17
Total Assets, 5 Yr. CAGR %	9.14	10.84	8.26	16.06	12.24
Tangible Book Value, 5 Yr. CAGR %	9	11.45	8.98	21.06	15.87
Common Equity, 5 Yr. CAGR %	9.7	11.89	8.49	19.51	15
Cash From Operations, 5 Yr. CAGR %	10.23	6.07	-6.2	10.41	-11.34
Capital Expenditures, 5 Yr. CAGR %	7.77	7.65	7.7	9.11	-0.46
Levered Free Cash Flow, 5 Yr. CAGR %	-10.19	-22.45	3.47	7.45	6.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.02	-22.73	2.3	6.22	4.17
Dividend Per Share, 5 Yr. CAGR %	4.56	6.34	4.84	9.14	11.84